Skip to content

Clinical trials

Phase 2 Uveitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis Phase: Phase 2 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20061
20071
20083
20091
20121
20131
20141
20151
20172
20191
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Unknown status2
Withdrawn2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)8
ACELYRIN Inc.2
Oregon Health and Science University2
Quan Dong Nguyen2
Aldeyra Therapeutics, Inc.1
Allergan1
Clearside Biomedical, Inc.1
Merrimack Pharmaceuticals1
Novartis1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis25
Uveitis, Posterior8
Uveitis, Intermediate7
Macular Edema5
Panuveitis5
Retinal Diseases3
Behcet Syndrome2
Inflammation2
Retinal Vasculitis2
Uveitis, Anterior2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.